Management of Delirium in Patients with Complex Medical Conditions

Introduction to Delirium Management

The American College of Emergency Physicians recommends prioritizing identifying and treating reversible causes of delirium while implementing non-pharmacological interventions first, reserving haloperidol only for severe hyperactive delirium that poses safety risks, and avoiding benzodiazepines entirely in this clinical context 1, 2

The Confusion Assessment Method (CAM) is a validated screening tool with 82-100% sensitivity and 89-99% specificity for delirium diagnosis, and should be used to confirm delirium diagnosis 3
Documenting acute onset, fluctuating course, inattention, and either altered consciousness or disorganized thinking as cardinal features is essential for diagnosis 3

The American College of Emergency Physicians suggests immediately evaluating for life-threatening complications, including monitoring vital signs continuously for autonomic instability 4, assessing hydration status and electrolyte disturbances 1, screening for infection 1, 2, evaluating for hypoxia and maximizing oxygen delivery 1, 2, reviewing all medications for anticholinergic burden and deliriogenic agents 1, 2, and assessing pain adequately and providing appropriate analgesia 1, 2

The American College of Emergency Physicians recommends implementing comprehensive environmental and supportive measures before considering medications, including providing a quiet room with adequate lighting 2, using noise-reduction strategies 2, displaying easily visible calendars and clocks 1, 2, maintaining consistency of caregivers 2, minimizing room relocations 2, frequently reassuring and reorienting the patient 1, 2, clearly identifying all caregivers 1, 2, carefully explaining all activities 1, 2, communicating clearly using simple language 2, encouraging family/friends to stay at bedside 2, and bringing familiar objects from home 2
Physiological support measures include providing sensory aids as appropriate 1, 2, regulating bowel and bladder function 1, 2, ensuring adequate nutrition 1, 2, increasing supervised mobility as tolerated 1, 2, and minimizing invasive interventions 2

The American College of Emergency Physicians suggests that haloperidol is recommended over lorazepam for acute treatment of severe hyperactive delirium posing safety risks 1, 2, and that benzodiazepines should be avoided entirely as they are strongly associated with increased delirium risk 5
Alternative routes of administration (buccal, intramuscular, subcutaneous, rectal) may be considered if needed, even if off-label 6

The American Academy of Neurology recommends waiting 2-4 weeks after complete delirium resolution before performing formal cognitive testing to avoid confounding dementia assessment 7
Documenting baseline cognitive function carefully for future comparisons is essential 7

Regular reevaluation of delirium screening is necessary as mental status changes wax and wane 1, 2
Monitoring for transition between hyperactive and hypoactive delirium subtypes is crucial 3
Tracking response to interventions and adjusting management accordingly is essential 1, 2

Benzodiazepines should not be used due to their strong association with delirium 5
Cognitive impairment should not be assumed to be solely due to baseline dementia without screening for delirium 1
Cognitive testing should not be performed during active delirium or immediately after resolution 7
Hypoactive delirium should not be overlooked, as it may be mistaken for sedation or depression 3
Physical restraints should not be used as first-line management 1, 2